Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Sep-23 6:00 PM View:  | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-23 | Sale | 705 | $1.06 | $747.30 | (< 1%) 452.53K to 451.83K | |
| 06-Jan-23 5:15 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 05-Jan-23 | Sale | 3,465 | $1.13 | $3,912.67 | (< 1%) 449.59K to 446.12K | |
| 06-Jan-23 5:15 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 04-Jan-23 | Sale | 8,179 | $1.13 | $9,272.66 | (2%) 457.76K to 449.59K | |
| 04-Jan-23 4:59 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-23 | Grant | 200,000 | -- | -- | 78% 257.76K to 457.76K | |
| 12-Jan-22 4:15 PM View: | Neostem, Inc. (LSTA) | 10-Jan-22 | Grant | 65,430 | -- | -- | 78% 83.76K to 149.19K | |
| 07-Jan-22 4:18 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 05-Jan-22 | Market Sale | 3,226 | $3.09 | $9,955.11 | (1%) 254.58K to 251.35K | 6% |
| 05-Jan-22 4:36 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 03-Jan-22 | Grant | 90,200 | -- | -- | 55% 164.38K to 254.58K | |
| 14-Dec-21 5:17 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 10-Dec-21 | Market Sale | 4,083 | $2.99 | $12,195.50 | (2%) 168.46K to 164.38K | (3%) |
| 10-Dec-21 5:07 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Dec-21 | Grant | 13,750 | -- | -- | 9% 154.71K to 168.46K | |
| 15-Oct-21 6:08 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 13-Oct-21 | Market Sale | 3,636 | $4.39 | $15,962.00 | (2%) 158.35K to 154.71K | 1% |
| 05-Oct-21 4:26 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 01-Oct-21 | Grant | 13,750 | -- | -- | 10% 144.6K to 158.35K | |
| 28-Sep-21 4:32 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 24-Sep-21 | Grant | 9,100 | -- | -- | 7% 135.5K to 144.6K | |
| 27-May-21 6:00 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 26-May-21 | Market Purchase | 20,000 | $3.99 | $79,850.00 | 17% 115.5K to 135.5K | 3% |
| 26-May-21 4:33 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 25-May-21 | Market Purchase | 5,000 | $3.48 | $17,400.00 | 5% 110.5K to 115.5K | 3% |
| 26-May-21 4:33 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 24-May-21 | Market Purchase | 12,500 | $3.32 | $41,497.50 | 13% 98.0K to 110.5K | 8% |
| 19-Mar-21 5:34 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 18-Mar-21 | Market Purchase | 10,000 | $4.50 | $45,000.00 | 11% 88.0K to 98.0K | (2%) |
| 19-Mar-21 5:34 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 17-Mar-21 | Market Purchase | 10,000 | $4.53 | $45,295.00 | 13% 78.0K to 88.0K | (3%) |
| 12-Jan-21 6:21 PM View: | Neostem, Inc. (LSTA) | 11-Jan-21 | Grant | 37,735 | -- | -- | 82% 46.02K to 83.76K | |
| 06-Jan-21 4:50 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 04-Jan-21 | Grant | 38,000 | -- | -- | 95% 40.0K to 78.0K | |
| 16-Dec-20 4:31 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Dec-20 | Market Purchase | 40,000 | $3.24 | $129,424.00 | 100% 0 to 40.0K | 1% |
| 14-Jan-20 4:19 PM View: | Neostem, Inc. (LSTA) | 13-Jan-20 | Grant | 18,292 | $3.28 | $59,997.80 | 66% 27.73K to 46.02K | |
| 16-Jan-19 4:13 PM View: | Neostem, Inc. (LSTA) | 14-Jan-19 | Grant | 12,121 | $4.95 | $59,998.90 | 78% 15.61K to 27.73K | < 1% |
| 10-Jan-19 12:28 PM View: | Neostem, Inc. (LSTA) | 08-Jan-19 | Grant | 8,747 | -- | -- | 127% 6.87K to 15.61K | |
| 15-Jun-18 4:02 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 13-Jun-18 | Option Exercise | 100,000 | $0.87 | $87,000.00 | 93% 107.33K to 207.33K | |
| 15-Jun-18 4:02 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 13-Jun-18 | Market Option Sale (Planned) | 100,000 | $7.51 | $751,000.00 | (48%) 207.33K to 107.33K | 49% |
| 12-Jun-18 4:51 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 08-Jun-18 | Option Exercise | 70,000 | $0.87 | $60,900.00 | 65% 107.33K to 177.33K | |
| 12-Jun-18 4:51 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 08-Jun-18 | Market Option Sale (Planned) | 70,000 | $5.86 | $409,997.00 | (39%) 177.33K to 107.33K | 35% |
| 18-May-17 5:00 PM View: | Neostem, Inc. (LSTA) | 16-May-17 | Grant | 2,565 | -- | -- | 60% 4.3K to 6.87K | |
| 31-Jan-17 6:51 PM View: | Neostem, Inc. (LSTA) | 09-Jan-17 | Grant | 1,650 | -- | -- | 62% 2.65K to 4.3K | |
| 23-Jun-16 5:54 PM View: | Neostem, Inc. (LSTA) | 22-Jun-16 | Grant | 7,500 | -- | -- | 39% 19.0K to 26.5K | |
| 27-Jan-16 9:41 PM View: | Neostem, Inc. (LSTA) | 25-Jan-16 | Grant | 9,000 | -- | -- | 90% 10.0K to 19.0K | |
| 12-Aug-15 5:02 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 12-Aug-15 | Market Purchase | 2,000 | $2.00 | $4,000.00 | 2% 105.33K to 107.33K | 91% |
| 04-Jun-15 9:04 PM View: | Neostem, Inc. (LSTA) | 02-Jun-15 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 01-Jun-15 4:39 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 01-Jun-15 | Market Purchase | 4,000 | $2.53 | $10,120.00 | 4% 101.33K to 105.33K | 51% |
| 15-Aug-14 9:04 AM View: | Pro-Pharmaceuticals Inc. (GALT) | 14-Aug-14 | Market Purchase | 4,000 | $4.46 | $17,837.80 | 4% 97.33K to 101.33K | (14%) |
| 14-Aug-14 10:37 AM View: | Pro-Pharmaceuticals Inc. (GALT) | 13-Aug-14 | Market Purchase | 1,000 | $4.42 | $4,415.50 | 1% 96.33K to 97.33K | (14%) |
| 10-Dec-13 5:05 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 09-Dec-13 | Market Purchase | 500 | $8.90 | $4,450.00 | < 1% 95.83K to 96.33K | (57%) |
| 05-Dec-13 6:41 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 05-Dec-13 | Market Purchase | 500 | $9.00 | $4,500.00 | < 1% 95.33K to 95.83K | (58%) |
| 19-Nov-13 1:20 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 19-Nov-13 | Market Purchase | 1,000 | $5.53 | $5,530.00 | 1% 94.33K to 95.33K | (31%) |
| 19-Nov-13 9:05 AM View: | Pro-Pharmaceuticals Inc. (GALT) | 18-Nov-13 | Market Purchase | 1,000 | $5.80 | $5,799.20 | < 1% 510.0K to 511.0K | (34%) |
| 15-Oct-12 5:14 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 12-Oct-12 | Market Purchase | 2,500 | $2.11 | $5,287.00 | < 1% 507.5K to 510.0K | 80% |
| 10-Oct-12 5:13 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 09-Oct-12 | Market Purchase | 2,500 | $2.00 | $5,000.00 | < 1% 505.0K to 507.5K | 91% |
| 09-Oct-12 5:20 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 08-Oct-12 | Market Purchase | 5,000 | $2.07 | $10,350.00 | < 1% 500.0K to 505.0K | 84% |
| 20-Feb-09 6:43 AM View: | Pro-Pharmaceuticals Inc. (GALT) | 13-Feb-09 | Grant | 500,000 | -- | -- | 100% 0 to 500.0K |